Michael D. Dake

Back to Profile

Publication Details

  • Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque.

    Celletti FL, Hilfiker PR, Ghafouri P, Dake MD. J Am Coll Cardiol. 2001; 37 (8): 2126-30

    This study was designed to evaluate the impact of recombinant human vascular endothelial growth factor165 (rhVEGF) on atherosclerotic plaque progression.

    PubMedID: 11419898

Stanford Medicine Resources:

Footer Links: